image
Healthcare - Medical - Care Facilities - NASDAQ - US
$ 8.62
-0.114 %
$ 61.9 M
Market Cap
-8.13
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one PIII stock under the worst case scenario is HIDDEN Compared to the current market price of 8.62 USD, P3 Health Partners Inc. is HIDDEN

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one PIII stock under the base case scenario is HIDDEN Compared to the current market price of 8.62 USD, P3 Health Partners Inc. is HIDDEN

This DCF valuation model was last updated on May, 8, 2025.

The intrinsic value of one PIII stock under the best case scenario is HIDDEN Compared to the current market price of 8.62 USD, P3 Health Partners Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart PIII

image
$10.0$10.0$9.0$9.0$8.0$8.0$7.0$7.0$6.0$6.0$5.0$5.0$4.0$4.0$3.0$3.0$2.0$2.0$1.0$1.0$0.0$0.015 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 AprMay '25May '25
FINANCIALS
1.5 B REVENUE
18.48%
-313 M OPERATING INCOME
-86.23%
-310 M NET INCOME
-437.24%
-110 M OPERATING CASH FLOW
-44.85%
14.5 M INVESTING CASH FLOW
895.02%
98.8 M FINANCING CASH FLOW
-1.56%
371 M REVENUE
2.36%
-139 M OPERATING INCOME
-29.45%
-233 M NET INCOME
-401.26%
-57.2 M OPERATING CASH FLOW
-153.06%
-475 K INVESTING CASH FLOW
-3.17%
33.7 M FINANCING CASH FLOW
1456.28%
Balance Sheet P3 Health Partners Inc.
image
Current Assets 184 M
Cash & Short-Term Investments 38.8 M
Receivables 125 M
Other Current Assets 20.1 M
Non-Current Assets 599 M
Long-Term Investments 0
PP&E 5.73 M
Other Non-Current Assets 594 M
4.95 %15.98 %75.76 %Total Assets$783.4m
Current Liabilities 496 M
Accounts Payable 64 M
Short-Term Debt 65 M
Other Current Liabilities 367 M
Non-Current Liabilities 137 M
Long-Term Debt 89.8 M
Other Non-Current Liabilities 47.7 M
10.10 %10.25 %57.96 %14.17 %7.52 %Total Liabilities$633.9m
EFFICIENCY
Earnings Waterfall P3 Health Partners Inc.
image
Revenue 1.5 B
Cost Of Revenue 1.65 B
Gross Profit -145 M
Operating Expenses 1.82 B
Operating Income -313 M
Other Expenses -2.22 M
Net Income -310 M
2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)(1b)(1b)(2b)(2b)2b(2b)(145m)(2b)(313m)2m(310m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
-9.66% GROSS MARGIN
-9.66%
-20.83% OPERATING MARGIN
-20.83%
-9.05% NET MARGIN
-9.05%
-178.90% ROE
-178.90%
-17.34% ROA
-17.34%
-90.08% ROIC
-90.08%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis P3 Health Partners Inc.
image
00(20m)(20m)(40m)(40m)(60m)(60m)(80m)(80m)(100m)(100m)(120m)(120m)20192019202020202021202120222022202320232024202420252025
Net Income -310 M
Depreciation & Amortization 86.1 M
Capital Expenditures 0
Stock-Based Compensation 5.75 M
Change in Working Capital 88 M
Others 118 M
Free Cash Flow -110 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets P3 Health Partners Inc.
image
PIII has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 13
6. Ownership
Insider Ownership P3 Health Partners Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
15.3 M USD 1
3-6 MONTHS
328 K USD 1
6-9 MONTHS
9 M USD 1
9-12 MONTHS
7. News
P3 Health Partners (PIII) Stock Jumps 8.9%: Will It Continue to Soar? P3 Health Partners (PIII) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. zacks.com - 1 month ago
P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. Management will give a presentation on Thursday, April 10, 2025, at 9:45 AM Pacific Time. A webcast of the presentation will be available on P3's Investor Relations Website at https://ir.p3hp.org/. A replay will be available on P3's in. businesswire.com - 1 month ago
P3 Health Partners Inc. (PIII) Q4 2024 Earnings Conference Call Transcript P3 Health Partners Inc. (NASDAQ:PIII ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Ryan Halsted - IR Aric Coffman - CEO Leif Pedersen - CFO Amir Bacchus - Chief Medical Officer Conference Call Participants Josh Raskin - Nephron Research David Larsen - BTIG Ryan Langston - TD Cowen Jack Senft - William Blair Operator Good day and welcome to the P3 Health Partners' Fourth Quarter 2024 Earnings Conference Call. All participants will be in a listen-only mode. seekingalpha.com - 1 month ago
P3 Health Partners Inc. (PIII) Reports Q4 Loss, Lags Revenue Estimates P3 Health Partners Inc. (PIII) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.22 per share a year ago. zacks.com - 1 month ago
P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. “Our business model remains fundamentally strong as we continue to deliver member and top-line growth, quality outcomes, and provider retention,” said Aric Coffman, CEO of P3. “With the $130M+. businesswire.com - 1 month ago
P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. Title & Webcast P3 Health Fourth Quarter Earnings Conference Cal. businesswire.com - 2 months ago
P3 Health Partners (PIII) Could Find a Support Soon, Here's Why You Should Buy the Stock Now P3 Health Partners (PIII) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. zacks.com - 2 months ago
P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts. Management is scheduled to host investor meetings on Wednesday March 5th, 2025. About P3 Health Partners (NASDAQ: PIII): P3 Health Partners Inc. is a leading population health management company committed to transfor. businesswire.com - 2 months ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms. globenewswire.com - 3 months ago
Kuehn Law Encourages Investors of P3 Health Partners Inc. to Contact Law Firm NEW YORK , Dec. 19, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of P3 Health Partners Inc. (NASDAQ: PIII) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. prnewswire.com - 4 months ago
P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference HENDERSON, Nev.--(BUSINESS WIRE)--P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time. A live webcast of the presentation will be available the following day on P3's Investor Relations Website: https://ir.p3. businesswire.com - 5 months ago
P3 Health Partners Inc. (PIII) Q3 2024 Earnings Call Transcript P3 Health Partners Inc. (NASDAQ:PIII ) Q3 2024 Results Conference Call November 12, 2024 4:30 PM ET Company Participants Ryan Halsted - Investor Relations Aric Coffman - Chief Executive Officer Leif Pedersen - Chief Financial Officer Amir Bacchus - Chief Medical Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Josh Raskin - Nephron Research Jenny Shen - BTIG Jack Senft - William Blair Operator Good day, and welcome to P3 Health Partners Third Quarter 2024 Earnings Call. [Operator Instructions] Please note, this event is being recorded. seekingalpha.com - 6 months ago
8. Profile Summary

P3 Health Partners Inc. PIII

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 61.9 M
Dividend Yield 0.00%
Description P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
Contact 2370 Corporate Circle, Henderson, NV, 89074 https://p3hp.org
IPO Date April 6, 2021
Employees 360
Officers Mr. Todd M. Smith Chief Legal Officer, Chief Compliance Officer & Corporate Secretary Mr. William Bettermann Executive Vice President & Chief Operating Officer Ms. Sarah Bussmann B.S.N., CRNI, M.H.A., R.N. Chief Administrative Officer Dr. Aric Coffman M.D. Chief Executive Officer & President Mr. Timothy Wilson Senior Vice President of Population Health Management Dr. Sherif Abdou F.A.C.E.P., FACP, M.D. Co-Founder & Vice Chairperson of the Board Mr. Devery Goodey Senior Vice President of Technology Mr. Leif Pedersen Chief Financial Officer Dr. Amir Bacchus M.B.A., M.D. Co-Founder, Chief Medical Officer & Director Ms. Kassi Belz APR Executive Vice President of Communications, Culture & Engagement